Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
77 hedge funds and large institutions have $87.1M invested in Calithera Biosciences, Inc in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 29 reducing their positions, and 11 closing their positions.
492% more call options, than puts
Call options by funds: $71K | Put options by funds: $12K
5% less funds holding
Funds holding: 81 → 77 (-4)
17% less capital invested
Capital invested by funds: $105M → $87.1M (-$17.8M)
17% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 29
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$8.18M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$3.72M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.26M |
| 4 |
Renaissance Technologies
New York
|
+$1.16M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$836K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
-$1.79M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.52M |
| 3 |
BlackRock
New York
|
-$1.48M |
| 4 |
JP Morgan Chase
New York
|
-$1.07M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$329K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IA
76
IFP Advisors
Tampa,
Florida
| $1K | – | – | – |
|
|
FAM
77
Fred Alger Management
New York
| – | -$294K | -2,800 | Closed |
|
78
Squarepoint
New York
| – | -$279K | -2,662 | Closed |
|
|
AIM
79
Alambic Investment Management
Belvedere,
California
| – | -$267K | -2,547 | Closed |
|
80
ProShare Advisors
Bethesda,
Maryland
| – | -$97K | -924 | Closed |
|
|
QSS
81
Quantitative Systematic Strategies
Ponte Vedra Beach,
Florida
| – | -$80K | -764 | Closed |
|
|
IWM
82
IHT Wealth Management
Chicago,
Illinois
| – | -$71K | -674 | Closed |
|
83
Ameriprise
Minneapolis,
Minnesota
| – | -$66K | -635 | Closed |
|
84
Russell Investments Group
London,
United Kingdom
| – | -$27K | -260 | Closed |
|
|
SWP
85
Stratos Wealth Partners
Beachwood,
Ohio
| – | -$9K | -86 | Closed |
|
86
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$3.06K | -31 | -91% |
|
|
SPIA
87
Steward Partners Investment Advisory
New York
| – | -$2K | -20 | Closed |
|
88
Daiwa Securities Group
Tokyo,
Japan
| – | -$1K | -10 | Closed |
|
CALA Hedge Fund Activity: Q4 2018 in Review
77 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q4 2018, worth a combined $87.1M — down 17% from $105M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CALA and 9 opened new positions — a net loss of 2 holders — while 29 trimmed existing stakes and 24 added.
The largest buyer was Federated Hermes, adding an estimated $8.18M. The largest seller was Man Group, cutting an estimated $1.79M.
- 77 institutional investors held Calithera Biosciences, Inc (CALA) as of Q4 2018, down from 81 in Q3 2018.
- Funds reported $87.1M of Calithera Biosciences, Inc stock for Q4 2018, down 17% quarter-over-quarter.
- 9 funds opened new Calithera Biosciences, Inc positions in Q4 2018 and 11 closed out, a net change of -2 holders.
- The largest Calithera Biosciences, Inc buyer in Q4 2018 was Federated Hermes, an estimated $8.18M added.
- The largest Calithera Biosciences, Inc seller in Q4 2018 was Man Group, an estimated $1.79M sold.
Based on aggregated 13F filings for Q4 2018.